Catalent's $100m IPO could be five times that, says investment firm

Catalent looks to go public with $100m IPO

By Dan Stanton

Catalent has filed an initial public offering (IPO) with the SEC to raise $100m though this could reach upwards of $500m, according to one investment firm.

PRA to buy CRI Lifetree

breaking news

PRA to buy CRI Lifetree

By Gareth Macdonald

US CRO PRA International has announced plans to buy privately-owned early phase trial specialist CRI Lifetree.

DrugDev looks to grow with CFS Clinical

DrugDev acquires site payment specialist CFS Clinical

By Zachary Brennan

Sponsor network developer DrugDev on Monday announced it would acquire CFS Clinical, which specializes in managing the financing of clinical trials.  Financial terms were not disclosed.

CML and AAIPharma consolidate CMC service

Cambridge Major Labs and AAIPharma Merge

By Dan Stanton

AAIPharma says the merger with Cambridge Major Laboratories (CML) will bring clients the benefits of integrated Chemistry and Manufacturing Controls (CMC) services from two high-growth CMOs.

PRA completes merger of RPS

PRA completes merger of RPS

The merger of PRA and RPS has been completed, creating the fourth largest contract research organisation (CRO).

CRA Acquires Psychiatric Clinical Trial Firm CCD

CRA Buys Psychiatric Trial Firm CCD

By Dan Stanton

Clinical Research Advantage (CRA) has acquired the late phase business of Comprehensive Clinical Development (CCD) adding psychiatric clinical trials to its services.

Follow us


View more